Loading…
HER2-Specific Peptide Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study
This study aims to prepare a novel breast cancer-targeted micelle-based nanocarrier, which is stable in circulation, allowing intracellular drug release, and to investigate its cytotoxicity, apoptosis, and cytostatic effects, in vitro. The shell part of the micelle is composed of zwitterionic sulfob...
Saved in:
Published in: | Pharmaceutics 2023-02, Vol.15 (3) |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 3 |
container_start_page | |
container_title | Pharmaceutics |
container_volume | 15 |
creator | Bayram, Nazende Nur Ulu, Gizem Tuğçe Abdulhadi, Nusaibah Abdulsalam Gürdap, Seda İşoğlu, İsmail Alper Baran, Yusuf İşoğlu, Sevil Dinçer |
description | This study aims to prepare a novel breast cancer-targeted micelle-based nanocarrier, which is stable in circulation, allowing intracellular drug release, and to investigate its cytotoxicity, apoptosis, and cytostatic effects, in vitro. The shell part of the micelle is composed of zwitterionic sulfobetaine ((N-3-sulfopropyl-N,N-dimethylamonium)ethyl methacrylate), while the core part is formed by another block, consisting of AEMA (2-aminoethyl methacrylamide), DEGMA (di(ethylene glycol) methyl ether methacrylate), and a vinyl-functionalized, acid-sensitive cross-linker. Following this, a targeting agent (peptide (LTVSPWY) and antibody (Herceptin[sup.®] )), in varying amounts, were coupled to the micelles, and they were characterized by [sup.1] H NMR, FTIR (Fourier-transform infrared spectroscopy), Zetasizer, BCA protein assay, and fluorescence spectrophotometer. The cytotoxic, cytostatic, apoptotic, and genotoxic effects of doxorubicin-loaded micelles were investigated on SKBR-3 (human epidermal growth factor receptor 2 (HER2)-positive) and MCF10-A (HER2-negative). According to the results, peptide-carrying micelles showed a higher targeting efficiency and better cytostatic, apoptotic, and genotoxic activities than antibody-carrying and non-targeted micelles. Also, micelles masked the toxicity of naked DOX on healthy cells. In conclusion, this nanocarrier system has great potential to be used in different drug-targeting strategies, by changing targeting agents and drugs. |
doi_str_mv | 10.3390/pharmaceutics15030733 |
format | article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A743769713</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A743769713</galeid><sourcerecordid>A743769713</sourcerecordid><originalsourceid>FETCH-LOGICAL-g673-a50830955072ebd71284e764430dd96cc5aa4fbaebd202ca3cd36d9d4141a9d13</originalsourceid><addsrcrecordid>eNptjE9LAzEQxYMoWGo_ghDwvDXZyW4ab3WprVBRbO91mszW6P4j2Qp-exf00INvDvN485vH2LUUUwAjbrt3DDVaOvbeRpkJEBrgjI2kMSZRJoXzE3_JJjF-iEEAcgZmxN5Wi9c02XRkfektf6Gu9474FsOBenK8aAPxIrQxJmvffA7Jk7dUVRR52QZ-HwhjzwtsLIU7Ph_4usOAvf8ivumP7vuKXZRYRZr87THbPiy2xSpZPy8fi_k6OeQaEszEDITJMqFT2jst05kinSsFwjmTW5shqnKPwy0VqUWwDnJnnJJKonESxuzmt_aAFe18U7Z9QFv7aHdzrUDnRksYqOk_1DCOam_bhko_5CcPP56AaOw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>HER2-Specific Peptide Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study</title><source>Publicly Available Content Database</source><source>PubMed Central (Training)</source><creator>Bayram, Nazende Nur ; Ulu, Gizem Tuğçe ; Abdulhadi, Nusaibah Abdulsalam ; Gürdap, Seda ; İşoğlu, İsmail Alper ; Baran, Yusuf ; İşoğlu, Sevil Dinçer</creator><creatorcontrib>Bayram, Nazende Nur ; Ulu, Gizem Tuğçe ; Abdulhadi, Nusaibah Abdulsalam ; Gürdap, Seda ; İşoğlu, İsmail Alper ; Baran, Yusuf ; İşoğlu, Sevil Dinçer</creatorcontrib><description>This study aims to prepare a novel breast cancer-targeted micelle-based nanocarrier, which is stable in circulation, allowing intracellular drug release, and to investigate its cytotoxicity, apoptosis, and cytostatic effects, in vitro. The shell part of the micelle is composed of zwitterionic sulfobetaine ((N-3-sulfopropyl-N,N-dimethylamonium)ethyl methacrylate), while the core part is formed by another block, consisting of AEMA (2-aminoethyl methacrylamide), DEGMA (di(ethylene glycol) methyl ether methacrylate), and a vinyl-functionalized, acid-sensitive cross-linker. Following this, a targeting agent (peptide (LTVSPWY) and antibody (Herceptin[sup.®] )), in varying amounts, were coupled to the micelles, and they were characterized by [sup.1] H NMR, FTIR (Fourier-transform infrared spectroscopy), Zetasizer, BCA protein assay, and fluorescence spectrophotometer. The cytotoxic, cytostatic, apoptotic, and genotoxic effects of doxorubicin-loaded micelles were investigated on SKBR-3 (human epidermal growth factor receptor 2 (HER2)-positive) and MCF10-A (HER2-negative). According to the results, peptide-carrying micelles showed a higher targeting efficiency and better cytostatic, apoptotic, and genotoxic activities than antibody-carrying and non-targeted micelles. Also, micelles masked the toxicity of naked DOX on healthy cells. In conclusion, this nanocarrier system has great potential to be used in different drug-targeting strategies, by changing targeting agents and drugs.</description><identifier>ISSN: 1999-4923</identifier><identifier>EISSN: 1999-4923</identifier><identifier>DOI: 10.3390/pharmaceutics15030733</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Antibodies ; Comparative analysis ; Drug delivery systems ; Drugs ; Identification and classification ; Materials ; Micelles ; Peptides ; Vehicles ; Viral antibodies</subject><ispartof>Pharmaceutics, 2023-02, Vol.15 (3)</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Bayram, Nazende Nur</creatorcontrib><creatorcontrib>Ulu, Gizem Tuğçe</creatorcontrib><creatorcontrib>Abdulhadi, Nusaibah Abdulsalam</creatorcontrib><creatorcontrib>Gürdap, Seda</creatorcontrib><creatorcontrib>İşoğlu, İsmail Alper</creatorcontrib><creatorcontrib>Baran, Yusuf</creatorcontrib><creatorcontrib>İşoğlu, Sevil Dinçer</creatorcontrib><title>HER2-Specific Peptide Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study</title><title>Pharmaceutics</title><description>This study aims to prepare a novel breast cancer-targeted micelle-based nanocarrier, which is stable in circulation, allowing intracellular drug release, and to investigate its cytotoxicity, apoptosis, and cytostatic effects, in vitro. The shell part of the micelle is composed of zwitterionic sulfobetaine ((N-3-sulfopropyl-N,N-dimethylamonium)ethyl methacrylate), while the core part is formed by another block, consisting of AEMA (2-aminoethyl methacrylamide), DEGMA (di(ethylene glycol) methyl ether methacrylate), and a vinyl-functionalized, acid-sensitive cross-linker. Following this, a targeting agent (peptide (LTVSPWY) and antibody (Herceptin[sup.®] )), in varying amounts, were coupled to the micelles, and they were characterized by [sup.1] H NMR, FTIR (Fourier-transform infrared spectroscopy), Zetasizer, BCA protein assay, and fluorescence spectrophotometer. The cytotoxic, cytostatic, apoptotic, and genotoxic effects of doxorubicin-loaded micelles were investigated on SKBR-3 (human epidermal growth factor receptor 2 (HER2)-positive) and MCF10-A (HER2-negative). According to the results, peptide-carrying micelles showed a higher targeting efficiency and better cytostatic, apoptotic, and genotoxic activities than antibody-carrying and non-targeted micelles. Also, micelles masked the toxicity of naked DOX on healthy cells. In conclusion, this nanocarrier system has great potential to be used in different drug-targeting strategies, by changing targeting agents and drugs.</description><subject>Antibodies</subject><subject>Comparative analysis</subject><subject>Drug delivery systems</subject><subject>Drugs</subject><subject>Identification and classification</subject><subject>Materials</subject><subject>Micelles</subject><subject>Peptides</subject><subject>Vehicles</subject><subject>Viral antibodies</subject><issn>1999-4923</issn><issn>1999-4923</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjE9LAzEQxYMoWGo_ghDwvDXZyW4ab3WprVBRbO91mszW6P4j2Qp-exf00INvDvN485vH2LUUUwAjbrt3DDVaOvbeRpkJEBrgjI2kMSZRJoXzE3_JJjF-iEEAcgZmxN5Wi9c02XRkfektf6Gu9474FsOBenK8aAPxIrQxJmvffA7Jk7dUVRR52QZ-HwhjzwtsLIU7Ph_4usOAvf8ivumP7vuKXZRYRZr87THbPiy2xSpZPy8fi_k6OeQaEszEDITJMqFT2jst05kinSsFwjmTW5shqnKPwy0VqUWwDnJnnJJKonESxuzmt_aAFe18U7Z9QFv7aHdzrUDnRksYqOk_1DCOam_bhko_5CcPP56AaOw</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Bayram, Nazende Nur</creator><creator>Ulu, Gizem Tuğçe</creator><creator>Abdulhadi, Nusaibah Abdulsalam</creator><creator>Gürdap, Seda</creator><creator>İşoğlu, İsmail Alper</creator><creator>Baran, Yusuf</creator><creator>İşoğlu, Sevil Dinçer</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20230201</creationdate><title>HER2-Specific Peptide Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study</title><author>Bayram, Nazende Nur ; Ulu, Gizem Tuğçe ; Abdulhadi, Nusaibah Abdulsalam ; Gürdap, Seda ; İşoğlu, İsmail Alper ; Baran, Yusuf ; İşoğlu, Sevil Dinçer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g673-a50830955072ebd71284e764430dd96cc5aa4fbaebd202ca3cd36d9d4141a9d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibodies</topic><topic>Comparative analysis</topic><topic>Drug delivery systems</topic><topic>Drugs</topic><topic>Identification and classification</topic><topic>Materials</topic><topic>Micelles</topic><topic>Peptides</topic><topic>Vehicles</topic><topic>Viral antibodies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bayram, Nazende Nur</creatorcontrib><creatorcontrib>Ulu, Gizem Tuğçe</creatorcontrib><creatorcontrib>Abdulhadi, Nusaibah Abdulsalam</creatorcontrib><creatorcontrib>Gürdap, Seda</creatorcontrib><creatorcontrib>İşoğlu, İsmail Alper</creatorcontrib><creatorcontrib>Baran, Yusuf</creatorcontrib><creatorcontrib>İşoğlu, Sevil Dinçer</creatorcontrib><jtitle>Pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bayram, Nazende Nur</au><au>Ulu, Gizem Tuğçe</au><au>Abdulhadi, Nusaibah Abdulsalam</au><au>Gürdap, Seda</au><au>İşoğlu, İsmail Alper</au><au>Baran, Yusuf</au><au>İşoğlu, Sevil Dinçer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HER2-Specific Peptide Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study</atitle><jtitle>Pharmaceutics</jtitle><date>2023-02-01</date><risdate>2023</risdate><volume>15</volume><issue>3</issue><issn>1999-4923</issn><eissn>1999-4923</eissn><abstract>This study aims to prepare a novel breast cancer-targeted micelle-based nanocarrier, which is stable in circulation, allowing intracellular drug release, and to investigate its cytotoxicity, apoptosis, and cytostatic effects, in vitro. The shell part of the micelle is composed of zwitterionic sulfobetaine ((N-3-sulfopropyl-N,N-dimethylamonium)ethyl methacrylate), while the core part is formed by another block, consisting of AEMA (2-aminoethyl methacrylamide), DEGMA (di(ethylene glycol) methyl ether methacrylate), and a vinyl-functionalized, acid-sensitive cross-linker. Following this, a targeting agent (peptide (LTVSPWY) and antibody (Herceptin[sup.®] )), in varying amounts, were coupled to the micelles, and they were characterized by [sup.1] H NMR, FTIR (Fourier-transform infrared spectroscopy), Zetasizer, BCA protein assay, and fluorescence spectrophotometer. The cytotoxic, cytostatic, apoptotic, and genotoxic effects of doxorubicin-loaded micelles were investigated on SKBR-3 (human epidermal growth factor receptor 2 (HER2)-positive) and MCF10-A (HER2-negative). According to the results, peptide-carrying micelles showed a higher targeting efficiency and better cytostatic, apoptotic, and genotoxic activities than antibody-carrying and non-targeted micelles. Also, micelles masked the toxicity of naked DOX on healthy cells. In conclusion, this nanocarrier system has great potential to be used in different drug-targeting strategies, by changing targeting agents and drugs.</abstract><pub>MDPI AG</pub><doi>10.3390/pharmaceutics15030733</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1999-4923 |
ispartof | Pharmaceutics, 2023-02, Vol.15 (3) |
issn | 1999-4923 1999-4923 |
language | eng |
recordid | cdi_gale_infotracmisc_A743769713 |
source | Publicly Available Content Database; PubMed Central (Training) |
subjects | Antibodies Comparative analysis Drug delivery systems Drugs Identification and classification Materials Micelles Peptides Vehicles Viral antibodies |
title | HER2-Specific Peptide Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T22%3A28%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HER2-Specific%20Peptide%20Targeted%20Core%20Cross-Linked%20Micelles%20for%20Breast%20Cancer:%20A%20Comparative%20Study&rft.jtitle=Pharmaceutics&rft.au=Bayram,%20Nazende%20Nur&rft.date=2023-02-01&rft.volume=15&rft.issue=3&rft.issn=1999-4923&rft.eissn=1999-4923&rft_id=info:doi/10.3390/pharmaceutics15030733&rft_dat=%3Cgale%3EA743769713%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g673-a50830955072ebd71284e764430dd96cc5aa4fbaebd202ca3cd36d9d4141a9d13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A743769713&rfr_iscdi=true |